In contrast, traditional aPLs (aCL and β2GPI) and newer aPLs directed against the D1 and D4/5 subunits of β2GPI were not associated with outcome after TIA and no antibodies were associated with atherosclerosis. Here, ACLY is linked to transient ischemic attack.